Home  »  Finance  »  PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes

PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes

http://photos.prnewswire.com/prnc/20110822/SF55808LOGOINCLINE VILLAGE, Nev., June 3, 2013 /PRNewswire/ — PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the adjusted conversion rate for the:

2.875% Convertible Senior Notes due February 15, 2015 (February 2015 Notes) is 176.389 shares of common stock per $1,000 principal…

Source: http://www.prnewswire.com/news-releases/pdl-biopharma-announces-conversion-rate-adjustments-for-convertible-notes-209974801.html

About the Author

has written 39276 stories on this site.

«
»
Copyright © 2010 Business and Corporate News.